| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/29/2009 | EP2081955A1 Metastin derivatives and use thereof |
| 07/29/2009 | EP2081952A2 Peptides |
| 07/29/2009 | EP2081598A2 Bioavailable combinations for hcv treatment |
| 07/29/2009 | EP2081594A1 Novel method for treating h.pylori infections |
| 07/29/2009 | EP2081589A2 Complementation of factor xi deficiency by factor v mutants |
| 07/29/2009 | EP2081588A1 Antimicrobial composition and uses thereof |
| 07/29/2009 | EP2081587A2 Alpha-msh therapies for treatment of autoimmune disease |
| 07/29/2009 | EP2081586A1 Rspondins as modulators of angiogenesis and vasculogenesis |
| 07/29/2009 | EP2081585A2 Cancer treatment |
| 07/29/2009 | EP2081584A2 Treatment of inflammation, demyelination and neuronal/axonal loss |
| 07/29/2009 | EP2081566A1 Improved biological effects of compositions comprising rosmarinic acid |
| 07/29/2009 | EP2081557A1 Colonic delivery using zn/pectin beads with a eudragit coating. |
| 07/29/2009 | EP2081552A2 Spontaneously forming ellipsoidal phospholipid unilamellar vesicles |
| 07/29/2009 | EP2081551A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 07/29/2009 | EP2081429A1 Methods relating to peripheral administration of nogo receptor polypeptides |
| 07/29/2009 | EP1993515B1 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
| 07/29/2009 | EP1987817B1 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 07/29/2009 | EP1828240B1 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/29/2009 | EP1793764A4 Growth factor encapsulation system for enhancing bone formation |
| 07/29/2009 | EP1694370A4 Wound care products containing keratin |
| 07/29/2009 | EP1670511B1 Cripto antagonism of activin and tgf-b signaling |
| 07/29/2009 | EP1558277A4 Treatment of inflammatory bowel disease |
| 07/29/2009 | EP1549679B1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 07/29/2009 | EP1435910B1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1399221B1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 07/29/2009 | EP1389043B1 Foot and mouth disease virus vaccine |
| 07/29/2009 | EP1293567B1 Ligand to gpr8 and dna thereof |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1287125B1 Dna sequences encoding dystrophin minigenes and methods of use thereof |
| 07/29/2009 | EP1086223B1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2009 | EP1073463B1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 07/29/2009 | EP0854726B2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 07/29/2009 | CN101495135A Treatment of pain by use of a single chain polypeptide fusion protein |
| 07/29/2009 | CN101495134A Compositions and methods for the delivery of nitric oxide |
| 07/29/2009 | CN101495133A Recombinant or transgenic factor VII compound having a majority of glycan, biantennary, bisialylated and non-fucosylated forms |
| 07/29/2009 | CN101495132A Insulin composition |
| 07/29/2009 | CN101495131A Novel antibacterial compounds |
| 07/29/2009 | CN101495130A Peptidyl diacylglycerides |
| 07/29/2009 | CN101491670A Method for treating cardiovascular disease using nervous regulation protein and composite |
| 07/29/2009 | CN101491669A Anti-anaemia fish-protein iron peptide capsule |
| 07/29/2009 | CN101491668A Composite with blood-sugar reducing function and preparation method thereof |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519581C Interferon-beta composite |
| 07/29/2009 | CN100518828C Prolonged release biodegradable microspheres and method for preparing same |
| 07/29/2009 | CN100518820C A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 07/29/2009 | CN100518819C Medical components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 07/29/2009 | CN100518818C Vaccine for preventing and/or treating tumour of digestive system |
| 07/29/2009 | CN100518817C Therapeutic agent to recover hematopoiesis function and its compositions and usage |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/29/2009 | CN100518815C Composition of amino acid |
| 07/29/2009 | CN100518814C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/29/2009 | CN100518718C Preparation of powder agglomerates |
| 07/28/2009 | US7566777 Genes encoding hormone and lytic peptides |
| 07/28/2009 | US7566774 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 07/28/2009 | US7566771 Humanised antibodies |
| 07/28/2009 | US7566769 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand "TRELL; gene therapy to treat tumors, autoimmune and inflammatory diseases or inherited genetic disorders |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566765 Heterocyclic compounds containing a nine-membered carbon-nitrogen ring |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566742 phosphoprotein preparation comprises a partially cross-linked partial hydrolysate of casein; a source of calcium ions; and a source of phosphate ions, or a source of strontium ions; calcium phosphate |
| 07/28/2009 | US7566741 Methods of inhibiting osteoclast activity |
| 07/28/2009 | US7566719 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 07/28/2009 | US7566697 chemically ligating two oligopeptides, a first oligopeptide thioester having an acidic C-terminal amino acid, having a thioester group, a side chain, side chain protecting group( phenylacryl ester), prevents rearrangements between atoms of the side chain and thioester, with 2nd oligopeptide |
| 07/28/2009 | US7566696 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 07/28/2009 | US7566695 Multimeric apoprotein agonists |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566691 Vasoactive intestinal polypeptide pharmaceuticals |
| 07/28/2009 | US7566690 Ace inhibitory peptides from plant materials |
| 07/28/2009 | US7566567 nontumorigenic, virally-immortalized human hepatocyte cell lines, that can be maintained in serum-free media, and produce endogenous plasma proteins, such as albumin, alpha -1 antitrypsin, blood clotting factors VIII and IX, |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration |
| 07/28/2009 | US7566466 Use of food and drink as a delivery system for phytase in humans |
| 07/28/2009 | US7566455 Vaccine with a component of a ubiquitin-ligase (E3) enzyme; regulation of gene expression, regulation of the cell-cycle, modification of cell surface receptors, biogenesis of ribosomes, and DNA repair |
| 07/28/2009 | US7566454 Immunization against influenza by administering codon-optimized forms of nucleic acids encoding influenza polypeptides such as influenza hemagglutinin (HA), neuraminidase (NA) |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566452 Treating cancer using antagonists to the endothelin B receptor (ETB) or inactive mimic forms of endothelin-1; melanoma |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | US7566448 Reduced aerosol generating formulations |
| 07/28/2009 | US7566447 Biocides |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | US7566444 Versatile hydrophilic dyes |
| 07/28/2009 | CA2435159C A method of preparing a collagen sponge |
| 07/28/2009 | CA2366996C Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/28/2009 | CA2178592C Long-acting injection suspensions and a process for their preparation |
| 07/23/2009 | WO2009091894A1 Ophthalmic preparations |
| 07/23/2009 | WO2009091810A1 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | WO2009091692A2 Malaria vaccine compositions and constituents which elicit cell mediated immunity |
| 07/23/2009 | WO2009091645A2 Compositions and methods for treating chondrosarcomas |
| 07/23/2009 | WO2009091615A2 Instruments and methods for inserting artificial intervertebral implants |
| 07/23/2009 | WO2009091550A2 Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
| 07/23/2009 | WO2009091341A1 Novel peptides and protein and uses thereof |
| 07/23/2009 | WO2009091059A1 Composition for diagnosis, treatment or prevention of epilepsy |